Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery, various products, and technologies to assist in surgical treatment of the ear, nose, and throat; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. The company primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange CNSX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolCNSX:SNN
Previous Symbol
CUSIPN/A
Phone44 20 7401 7646
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees15,000
Outstanding SharesN/A
Market Cap$0.00
OptionableOptionable
Sunniva (CNSX:SNN) Frequently Asked Questions
What is Sunniva's stock symbol?
Sunniva trades on the CNSX under the ticker symbol "SNN."
What price target have analysts set for SNN?
2 brokers have issued 1 year price objectives for Sunniva's stock. Their predictions range from $13.00 to $39.49. On average, they anticipate Sunniva's stock price to reach $26.2450 in the next twelve months. This suggests a possible upside of 665.2% from the stock's current price. View Analyst Price Targets for Sunniva.
What is the consensus analysts' recommendation for Sunniva?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sunniva in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sunniva.
Has Sunniva been receiving favorable news coverage?
News articles about SNN stock have been trending very positive this week, InfoTrie reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sunniva earned a media sentiment score of 3.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days.
Who are some of Sunniva's key competitors?
Some companies that are related to Sunniva include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Avacta Group (AVCT), Azure Healthcare (AZV), Biosig Technologies (BSGM), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD) and Ellex Medical Lasers (ELXMF).
Who are Sunniva's key executives?
Sunniva's management team includes the folowing people:
- Mr. Graham Timothy Baker, CFO & Exec. Director (Age 50)
- Mr. Namal Nawana, CEO & Exec. Director (Age 47)
- Mr. Mark Gladwell, Pres of Global Operations (Age 43)
- Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 45)
- Mr. Joe Metzger, Sr. VP of Marketing Services & Communications
How do I buy shares of Sunniva?
Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Sunniva's stock price today?
One share of SNN stock can currently be purchased for approximately $3.43.
What is Sunniva's official website?
How can I contact Sunniva?
The company can be reached via phone at 44 20 7401 7646.
MarketBeat Community Rating for Sunniva (CNSX SNN)
MarketBeat's community ratings are surveys of what our community members think about Sunniva and other stocks. Vote "Outperform" if you believe SNN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNN will underperform the S&P 500 over the long term. You may vote once every thirty days.
